Ables Iannone Moore & Associates’s Eli Lilly LLY Stock Holding History

Ables Iannone Moore & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.55M	Sell	1,342 -1	-0.1%	-$1.18K	0.81%	25
2026 Q2	$1.61M	Sell	1,343 -27	-2%	-$27.6K	0.86%	24
2026 Q1	$1.26M	Buy	1,370 +7	+0.5%	+$7.1K	0.75%	29
2025 Q4	$1.46M	Sell	1,363 -39	-3%	-$37.3K	0.8%	24
2025 Q3	$1.07M	Sell	1,402 -15	-1%	-$11.2K	0.62%	31
2025 Q2	$1.1M	Buy	1,417 +131	+10%	+$102K	0.69%	29
2025 Q1	$1.06M	Buy	1,286 +121	+10%	+$101K	0.72%	28
2024 Q4	$899K	Buy	+1,165	New	+$965K	0.56%	31
2024 Q1	–	Sell	-210	Closed	-$122K	–	186
2023 Q4	$122K	Buy	+210	New	+$123K	0.09%	63

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

Ables Iannone Moore & Associates's LLY Position: Q3 2026 in Review

Ables Iannone Moore & Associates reduced its Eli Lilly (LLY) stake by 0.07% in Q3 2026, selling an estimated $1.18K and leaving 1,342 shares worth $1.55M. The position accounts for 0.81% of the portfolio, ranked #25.

Ables Iannone Moore & Associates first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.61M in Q2 2026. 1,163 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Ables Iannone Moore & Associates held 1,342 shares of Eli Lilly worth $1.55M as of Q3 2026.
Ables Iannone Moore & Associates sold 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
Eli Lilly made up 0.81% of Ables Iannone Moore & Associates's portfolio in Q3 2026, its #25 holding.
Ables Iannone Moore & Associates first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
Ables Iannone Moore & Associates's Eli Lilly position peaked at $1.61M in Q2 2026.
1,163 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q3 2026, filed 6 Oct 2026.